房颤患者口服抗凝治疗与痴呆风险降低相关
AIMS: The association between atrial fibrillation (AF) and dementia is well documented, but it is not clear if oral anticoagulant treatment offers protection.…
要点
- 房颤患者未接受口服抗凝治疗者痴呆风险更高。
- 基线抗凝与痴呆风险降低29%相关,按治疗分析降低48%。
- 新型口服抗凝药与华法林在痴呆风险上无显著差异。
核心结论
- 房颤患者未接受口服抗凝治疗时痴呆风险更高,早期启动抗凝可能有助于保护认知功能。
研究设计与样本
- 采用倾向评分匹配、伪造终点及意向治疗和按治疗原则分析。
主要发现
- 基线接受抗凝治疗者较未接受者痴呆风险降低29%(HR 0.71,95%CI 0.68-0.74)。
- 新型口服抗凝药与华法林直接比较未见痴呆风险差异(HR 0.97,95%CI 0.67-1.40)。
临床怎么用
- 对房颤患者应评估抗凝指征,早期启动口服抗凝治疗可能有助于降低痴呆风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: The association between atrial fibrillation (AF) and dementia is well documented, but it is not clear if oral anticoagulant treatment offers protection. The aim of the study is therefore to compare the incidence of new dementia in patients with AF with and without oral anticoagulants, and to explore if there is a difference between novel anticoagulants and warfarin in this respect. METHODS AND RESULTS: Retrospective registry study of all patients with hospital diagnosis of AF and no previous diagnosis of dementia in Sweden between 2006 and 2014. Propensity score matching, falsification endpoints, and analyses according to intention to treat as well as on-treatment principles were used. The study included 444 106 patients and over 1.5 million years at risk. Patients on anticoagulant treatment at baseline was associated with 29% lower risk of dementia than patients without anticoagulant treatment [hazard ratio (HR) 0.71, 95% confidence intervals (95% CI) 0.68-0.74] and 48% lower risk analysed on treatment (HR 0.52, 95% CI 0.50-055). Direct comparison between new oral anticoagulants and warfarin showed no difference (HR 0.97, 95% CI 0.67-1.40). CONCLUSION: The risk of dementia is higher without oral anticoagulant treatment in patients with AF. This suggests that early initiation of anticoagulant treatment in patients with AF could be of value in order to preserve cognitive function.
引用
- Friberg L, Rosenqvist M. Less dementia with oral anticoagulation in atrial fibrillation. Eur Heart J. 2018. PMID: 29077849. doi:10.1093/eurheartj/ehx579
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。